Literature DB >> 6657546

Acute polyarthritis following the use of Corynebacterium parvum vaccine (Coparvax) for malignant pleural effusion.

A M Lever, J Forsythe, P Oxford.   

Abstract

A 77-year-old man with a malignant pleural effusion was treated by aspiration of fluid and injection of Corynebacterium parvum vaccine for pleurodesis. Within 24 hr he had developed a temperature and a neutropenia followed by an acute crippling polyarthritis of his hands and wrists which subsequently responded to oral steroids and non-steroidal antiinflammatory drugs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6657546      PMCID: PMC2417804          DOI: 10.1136/pgmj.59.698.799

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  4 in total

1.  Surgical adjuvant therapy of malignant melanoma with corynebacterium parvum.

Authors:  E Y Hilal; C M Pinsky; Y Hirshaut; H J Wanebo; J A Hansen; D W Braun; J G Fortner; H F Oettgen
Journal:  Cancer       Date:  1981-07-15       Impact factor: 6.860

2.  Inhibition of tumour growth by administration of killed corynebacterium parvum.

Authors:  B N Halpern; G Biozzi; C Stiffel; D Mouton
Journal:  Nature       Date:  1966-11-19       Impact factor: 49.962

3.  Toxicity manifestations following intravenous Corynebacterium parvum administration to patients with ovarian and cervical carcinoma.

Authors:  S A Gall; P J DiSaia; H Schmidt; L Mittelstaedt; P Newman; W Creasman
Journal:  Am J Obstet Gynecol       Date:  1978-11-01       Impact factor: 8.661

4.  Intrapleural immunotherapy with Corynebacterium parvum in recurrent malignant pleural effusions.

Authors:  J W Millar; A M Hunter; N W Horne
Journal:  Thorax       Date:  1980-11       Impact factor: 9.139

  4 in total
  2 in total

1.  Can immunisation trigger rheumatoid arthritis?

Authors:  D P Symmons; K Chakravarty
Journal:  Ann Rheum Dis       Date:  1993-12       Impact factor: 19.103

2.  COVID-19 vaccine and boosted immunity: Nothing ad interim to do?

Authors:  Luca Roncati; Maria Vadalà; Veronica Corazzari; Beniamino Palmieri
Journal:  Vaccine       Date:  2020-10-09       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.